Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma

IntroductionPancreatic cancer is a truculent disease with limited treatment options and a grim prognosis. Immunotherapy has shown promise in treating various types of cancer, but its effectiveness in pancreatic cancer has been lacking. As a result, it is crucial to identify markers associated with i...

Descripció completa

Dades bibliogràfiques

Autors principals:	Fereshteh Rezagholizadeh, Fatemeh Tajik, Morteza Talebi, Seyed Reza Taha, Mahdieh Shariat Zadeh, Pooya Farhangnia, Hamideh Sadat Hosseini, Aram Nazari, Shabnam Mollazadeh Ghomi, Seyede Mahtab Kamrani Mousavi, Niloofar Haeri Moghaddam, Hossein Khorramdelazad, Mohammad Taghi Joghataei, Elahe Safari
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-01-01
Col·lecció:	Frontiers in Immunology
Matèries:	VISTA PDAC CD68 pancreatic ductal adenocarcinoma prognosis biomarker
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1283364/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!